Drugs Containing Excipient (Inactive Ingredient) TALC

Branded drugs containing TALC excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	INLURIYO	imlunestrant	0002-1717	TALC	2030-09-25
Eli Lilly and Company	CYMBALTA	duloxetine hydrochloride	0002-3235	TALC
Eli Lilly and Company	OLUMIANT	baricitinib	0002-4182	TALC
Eli Lilly and Company	REYVOW	lasmiditan	0002-4312	TALC	2037-12-05
Eli Lilly and Company	CIALIS	tadalafil	0002-4465	TALC
Eli Lilly and Company	VERZENIO	abemaciclib	0002-4483	TALC	2031-09-28
ER Squibb & Sons LLC	COBENFY	xanomeline and trospium chloride	0003-0050	TALC	2029-09-26

Generic drugs containing TALC excipient

Company	Ingredient	NDC	Excipient
Eli Lilly and Company	imlunestrant	0002-1717	TALC
Eli Lilly and Company	duloxetine hydrochloride	0002-3235	TALC
Eli Lilly and Company	baricitinib	0002-4182	TALC
Eli Lilly and Company	lasmiditan	0002-4312	TALC
Eli Lilly and Company	tadalafil	0002-4465	TALC
Eli Lilly and Company	abemaciclib	0002-4483	TALC
ER Squibb & Sons LLC	xanomeline and trospium chloride	0003-0050	TALC

Market Dynamics and Financial Trajectory for Talc in the Pharmaceutical Excipients Sector

Last updated: February 8, 2026

Market Overview
Talc remains a key excipient in pharmaceutical manufacturing, used primarily as a bulking, anti-caking, and lubricant agent. The global talc market for pharmaceutical applications was valued at approximately $200 million in 2022. It is projected to reach $260 million by 2028, with a compound annual growth rate (CAGR) of around 4.4% (Source: MarketsandMarkets).

Supply Chain and Raw Material Factors

1. Source Concentration: Approximately 70% of global talc production occurs in China, India, Brazil, and the United States. China holds nearly 50% of the global supply, leading to market concentration risks.
2. Extraction and Quality: Talc quality for pharma demands high purity, typically containing less than 0.5% asbestos contamination. Rigorous testing and regulatory compliance add to processing costs.
3. Environmental Regulations: Stricter environmental and health regulations influence mining practices, delaying new projects and increasing costs.

Regulatory Landscape

1. Asbestos Contamination Concerns: Regulatory agencies like the FDA and EPA enforce strict limits on asbestos in talc products, impacting processing and testing costs. A notable legal case involved Johnson & Johnson's talc-based products, with ongoing litigation over contamination concerns.
2. Reclassification and Testing: Increased regulatory scrutiny leads to more comprehensive testing, affecting supply stability and costs.

Market Drivers

• Growing Pharma Industry: The global pharmaceutical sector grew at 4.5% annually from 2018–2022. Increased production boosts demand for excipients like talc.
• Demand from Generic and OTC Drugs: Mass-produced medicines frequently incorporate talc for the powder form, expanding use cases.
• Preference for Inert Fillers: Talc is favored for its inert nature, high coverage, and cost efficiency relative to alternatives.

Market Challenges

• Safety and Regulatory Risks: Legal liabilities and health concerns pose significant risk factors. Litigation over asbestos content has affected brand reputation and led to bans or restrictions in various jurisdictions.
• Alternative Excipient Competition: The rise of alternatives like magnesium stearate and microcrystalline cellulose offers substitutes, pressuring talc prices.
• Environmental and Ethical Sourcing Risks: Mining practices under scrutiny could cause supply disruptions.

Financial Trajectory

1. Pricing Trends: Talc prices in pharma vary from $2.50 to $4.50 per kilogram based on purity and source, with premium grades commanding higher premiums. Price increases of 2-3% annually are projected, driven by inflation and stricter quality controls.
2. Profit Margins: Manufacturing margins hover around 15-20%, influenced by raw material costs and regulatory expenses.
3. Investment and M&A Activity: Several companies, including Imerys, Excalibar, and Golcha, pursue vertical integration and quality enhancements. Mergers and acquisitions focus on securing supply chains and acquiring safety certifications.

Forecast Considerations

• Medical demand growth supports steady demand; however, regulatory risks could temper volume growth.
• Industry shifts toward safer, asbestos-free talc could increase processing costs but also open premium markets.
• Potential supply disruptions could elevate prices unexpectedly, especially if China's supply is affected.

Key Financial Indicators (2022–2028)	Year	Market Value (USD million)	CAGR	Price Range (per kg)	Major Price Drivers
2022	200	—	$2.50–$4.50	Supply stability, regulatory compliance
2023	208	4.0%	$2.55–$4.60	Raw material costs, demand stability
2024	217	4.0%	$2.60–$4.65	Regulatory tightening, supply constraints
2025	226	4.0%	$2.65–$4.70	Market consolidation, substitution threat
2026	236	4.0%	$2.70–$4.75	Increased safety regulations
2027	246	3.8%	$2.75–$4.80	Technological innovations, safety investments
2028	260	4.4%	$2.80–$4.85	Consumer safety focus, market demand growth

Summary
Global talc demand in pharmaceutical applications reflects consistent growth aligned with the broader pharma industry expansion. Prices are sensitive to regulatory changes, supply chain dynamics, and evolving safety standards. Companies investing in high-purity, asbestos-free sources and diversifying supply sources are positioned to capitalize on market stability.

---

Key Takeaways

• The pharmaceutical talc market is projected to grow at roughly 4.4% CAGR from 2022-2028.
• China dominates supply but poses risks due to environmental regulation and geopolitical factors.
• Regulatory risks, especially relating to asbestos contamination, influence costs and supply security.
• Alternative excipients and substitution pressures add competitive dynamics.
• Price growth is modest but susceptible to supply disruptions and regulatory shifts.

---

Frequently Asked Questions

1. How significant are regulatory risks for talc in pharmaceuticals?
Regulatory risks stem from concerns over asbestos contamination. Agencies like the FDA enforce strict limits, and legal cases have led to bans or restrictions, impacting supply and costs.

2. What are the main competitors to talc in pharmaceutical excipients?
Magnesium stearate and microcrystalline cellulose are primary substitutes. They offer comparable functional benefits with potentially fewer regulatory hurdles but may be more expensive.

3. How does supply concentration in China influence the market?
Heavy reliance on Chinese sources exposes the market to geopolitical, environmental, and regulatory risks, potentially causing price volatility or supply shortages.

4. What innovations could impact talc demand?
Development of asbestos-free, high-purity talc and alternative inert fillers could reshape the market, especially as safety concerns intensify.

5. What is the outlook for investment in talc-related supply chain infrastructure?
Investments aimed at improving purity, safety, and sustainability are critical. Vertical integration by large suppliers helps secure margins amid regulatory and market pressures.

---

Sources
[1] MarketsandMarkets, "Talc Market for Pharmaceutical Applications," 2022.